Loading...
Loading...
Stifel Nicolaus cuts its target price on Buy-rated Brookdale Senior Living
BKD by $1 to $24 on cuts to reimbursements.
Stifel Nicolaus says, "Lowering 2012 EPS and CFFO per share estimates by $0.18 to $0.17 and by $0.14 to $2.22, respectively. Higher impact from skilled nursing reimbursement is primary reason for lower EPS and CFFO estimates, offset some by higher occupancy growth assumptions. We are above the top range of management guidance for 2012 CFFO ($2.10 - $2.20/sh) as we model slight (10 bps) margin improvement versus management guidance for flat margins."
BKD closed at $18.80 a share on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in